"Onglyza - API Insight, 2020" report provides product and API manufacturers details across US, Europe, China and India for Onglyza . It includes Onglyza overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Onglyza’s patents information (US & EU). It also features the historical and forecasted sales of Onglyza till 2022. The report also highlights Onglyza’s market competition and emerging therapies which are in the same space as Onglyza
Methodology Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis ’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
Patent information around Onglyza in United States (US) and Europe (EU) has been highlighted
API manufacturers for Onglyza in United States, Europe, China and India
The report contains historical and forecasted sales for Onglyza till 2022
Enlists the market competition and emerging therapies in the space where Onglyza operates
Reasons to Buy Establish a comprehensive understanding of the drug, Onglyza
Access to Onglyza’s API manufacturers details to devise API procurement strategy for generic development
Plan generic developmental timelines around Onglyza’s patents for the major markets- US and EU
Understand Onglyza’s current and future growth through its historical and forecasted sales
Identify the current in-market competitors for Onglyza
Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
Identify the emerging players and their products operating in the same space as Onglyza.
Our reports have been used by over 10K customers, including:
The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech...
Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships Summary This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020).IT...
The analyst presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the market’s maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations...
The ePRO, ePatient Diaries, and eCOA market in Middle East and Africa is expected to grow from US$ 48.4 million in 2021 to US$ 112.3 million by 2028; it is estimated to grow at a CAGR of 12.8% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. Mobile-enabled...
The ePRO, ePatient Diaries, and eCOA market in North America is expected to grow from US$ 607.2 million in 2021 to US$ 1,640.6 million by 2028; it is estimated to grow at a CAGR of 15.3% from 2021 to 2028. Increasing number of smartphone users is likely to boost the ePRO, e-Patient Diaries, and eCOA’s adoption in the coming years. As per the...
The ePRO, ePatient Diaries, and eCOA market in South and Central America is expected to grow from US$ 90.3 million in 2021 to US$ 229.0 million by 2028; it is estimated to grow at a CAGR of 14.2% from 2021 to 2028. Patient centricity means designing a treatment, clinical trial, or other health solution centered around the patient. Creating...
The aptamers market valued at an estimated USD 151 million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during the forecast period. Growth of aptamers market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages...
Forecasts by Type (Drug Development, Drug Discovery), by Phase (Preclinical Testing, Clinical Trials, Other), by End-user (Pharmaceutical, Biotechnology, Contract Research Organisations, Research Institutes, Other), by Function (Target Data, Sequencing & Target Data Analysis, Docking, Molecular Modelling, High Throughput Screening...
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.